Request Sample

Global Neurological Disorder Diagnostics Market

March 16, 2018

Global Neurological Disorder Diagnostics Market, By Technology (Imaging (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging, Positron Emission Tomography (PET), Single-photon Emission Computed Tomography (SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electroencephalography (EEG), Magnetoencephalography (MEG)), and In Vitro Diagnostics (Biomarker, Biopsy, and Others), By Disease Indication (Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease (HD), Multiple Sclerosis, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR224      
Pages :284 Pages
Format :   PPT Format   PDF Format

The global neurological disorder diagnostics market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Neurological disorder diagnostics tools are used for diagnosing various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. Neurological disorder diagnostics procedures include computed tomography scan (also called as CT or CAT scan), electroencephalogram (EEG), magnetic resonance imaging (MRI), electrodiagnostic tests, such as electromyography (EMG) and nerve conduction velocity (NCV), positron emission tomography (PET), and others.

Table 1. Global neurological disorder diagnostics market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Technology)

Imaging (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging, Positron Emission Tomography (PET), Single-photon Emission Computed Tomography (SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electroencephalography (EEG), Magnetoencephalography (MEG)), and In Vitro Diagnostics (Biomarker, Biopsy, and Others)

Market Segmentation (By Disease Indication)

Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease (HD), Multiple Sclerosis, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others

Market Segmentation (By End User)

Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, FUJIFILM Holdings Corporation, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Lifelines Neuro Company, Natus Medical Incorporated, Neusoft Medical Systems, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, and Canon Medical Systems Corporation., among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Increasing prevalence of neurological disorders such as Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, and others among the population is expected to propel the growth of the global neurological disorder diagnostics market. For instance, according to Alzheimer’s Association, in 2019, around 5.8 million of the U.S. adults and aged people were diagnosed with Alzheimer’s Disease or other dementias. The number of the patients is estimated to increase in the near future, which will increase the number of the neurological disorder diagnostics procedures.

Moreover, adoption of inorganic strategies such as collaboration and partnerships are contributing to growth of the global neurological disorder diagnostics market. For instance, in March 2018, Canon Medical Systems, Kumamoto University, and University of Bordeaux entered into a collaborative research for the development of deep learning technology in magnetic resonance imaging.

However, risk and disadvantages associated with neurological disorder diagnostics techniques are anticipated to hamper the global neurological disorder diagnostics market growth. For example, MRI cannot be performed on patients with implanted pacemakers, certain prosthetic devices, implanted drug infusion pumps, and epilepsy. Moreover, high cost of these diagnostic techniques makes patients reluctant to buy in low- and middle-income countries of Latin America, Middle East and Africa. These factors may negatively affect the neurological disorder diagnostics market growth.

Figure 1. PORTER’S Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

North America is anticipated to hold a leading position in the global neurological disorder diagnostics market owing to presence of a highly developed healthcare system, high adoption of innovative neurodiagnostic tools among medical professionals, and presence of neurodiagnostic devices manufacturing companies such as GE Healthcare, Lifelines Neuro Company, LLC, Natus Medical Incorporated, Advanced Brain Monitoring in the region. Approvals and launches of neurological disorder diagnostics tools and techniques by these manufacturers is expected to drive the market growth in North America. For instance, in June 2017, Neusoft Medical Systems received the U.S. Food and Drug Administration approval for an innovative CT scanner NeuViz Prime CT Scanner.

Figure 2. Regional Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players involved in global neurological disorder diagnostics market include: Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, FUJIFILM Holdings Corporation, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Lifelines Neuro Company, Natus Medical Incorporated, Neusoft Medical Systems, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, and Canon Medical Systems Corporation., among others.

Manufacturers operating in neurological disorder diagnostics market are continually focusing on the launching of innovative products with advanced technologies. For instance, in November 2016, Koninklijke Philips N.V. launched IQon Spectral CT in Canada. IQon Spectral CT is a spectral detector CT, designed specifically for spectral imaging. Also, rise in strategic acquisitions and partnerships among players to enhance their portfolio of neurological disorder diagnostics products is also expected to boost the market growth.

 

Figure 3. Market Share of Key Players, 2019

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

By Technology

  • Imaging
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Nuclear Medicine Imaging
    • Positron Emission Tomography (PET)
    • Single-photon Emission Computed Tomography (SPECT)
    • Near Infrared Spectroscopic Imaging (NIRS)
    • Electroencephalography (EEG)
    • Magnetoencephalography (MEG)
  • In Vitro Diagnostics
    • Biomarker
    • Biopsy
    • Others

By Disease Indication

  • Alzheimer’s Disease (AD)
  • Parkinson’s Disease (PD
  • Amyotrophic Lateral Sclerosis (ALS
  • Huntington's Disease (HD)
  • Multiple Sclerosis
  • Paraneoplastic Syndrome
  • Paraproteinemic Neuropathies
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Ambulatory Care Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global neurological disorder diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global neurological disorder diagnostics market?
  • What key factors are expected to increase the demand for global neurological disorder diagnostics market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global neurological disorder diagnostics market?
  • Which technology (imaging (computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging, positron emission tomography (PET), single-photon emission computed tomography (SPECT), near infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG)), and in vitro diagnostics (biomarker, biopsy, and others)) is expected to dominate the global neurological disorder diagnostics market in the coming years?
  • Which disease indication is expected to propel the market in the foreseen future?
  • Which end user contribute highest CAGR (%) in the neurological disorder diagnostics market?
  • What was the total revenue generated by the global neurological disorder diagnostics market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global neurological disorder diagnostics market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the global neurological disorder diagnostics market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact in the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.